Until now, our medical approach has been reactive, with secondary prevention at best. A patient has a heart attack; we put them on statins and aspirin to prevent another event. For a diabetic, we treat blood sugar and lower the hemoglobin A1c. While there has been steady improvement in cancer treatments and less reliance on classic chemotherapy, most patients are not getting diagnosed early and the prognosis has extended survival a matter of months for many of the most successful new treatments. We’re in a reactive rut. But now we have the chance to fulfill the ultimate medical dream of
...more
